info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Cancer Registry Software Market Trends

ID: MRFR//6380-HCR | 90 Pages | Author: Kinjoll Dey| July 2024

Cancer Registry Software Market Overview


Cancer Registry Software Market Size was valued at USD 0.19 Billion in 2023. The Global Cancer Registry Software industry is projected to grow from USD 0.20 Billion in 2024 to USD 0.36 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.21% during the forecast period (2024 - 2032).

A cancer registry is a software database for organizing, collecting, and storing data of cancer patients for evaluation of their treatment outcomes. This software tool helps manage and provide access to information and build cancer registries.


The market’s growth is driven by the demand for proper management of cancer and the rising demand to improve the quality of care and reduce healthcare costs. The higher adoption of EHRs and the increased usage of cancer patient registry data for marketing surveillance are driving the market.


The usage of integrated software in the healthcare industry is mainly due to the changing landscape; the demand for proper streamlined and optimized workflows and decreased physician workloads are enhancing the market’s growth. Other factors such as the emerging government’s focus on population growth, health management, investment in the healthcare sector, and eliminating the higher healthcare costs will boost the market’s growth in the forecast period.


Soon, market growth is anticipated to be boosted by rising cancer prevalence, bettering healthcare quality, cutting healthcare expenses, and recent actions by key players such as product/service announcements and mergers and acquisitions. A rise in the use of cancer registry software is predicted due to many benefits, including effective workflow leadership, automated case registries, and the rising incidence of cancer. Additionally, many government agencies are making efforts, and supporting the development of cancer registries is anticipated to accelerate market expansion. Like this, approvals for products and debuts are other variables for market expansion. Such an abundance of operations demonstrates the high rate of patient adoption of surgery, and as a result, growth is anticipated.


Due to hospitals' huge investments and funding, patients would prefer hospitals if there were more surgeries since they would receive better care there than at other institutions. The main reason driving the market's expansion globally is the rising use of electronic health records (EHR) and additional e-health technologies like ePrescribing, telemedicine, and others. The demand for proper, streamlined, optimized workflows and reduced physician workloads is boosting the market's growth. This is why integrated software is used in the healthcare sector. Population expansion, health management, investments in the healthcare sector, and eliminating the higher healthcare expenses are other aspects that will enhance the market's growth during the projection period. In addition, user-friendly cloud-based patient registration systems have become an effective tool with improved data accessibility and immediate evaluation for end users.


Cancer Registry Software Market Segment


The cancer registry software market has been segmented into type, deployment model, database type, functionality, and end user.


By type, the market has been segmented into integrated software and standalone software.


Based on the deployment model, the market has been segmented into cloud-based models and on-premise models.


On the basis of the database type, the market has been segmented into commercial databases and public databases.


By functionality, the market has been segmented into patient care management, product outcome evaluation, cancer reporting to meet state and federal regulations, medical research & clinical studies.


The market, by end user, has been segmented into hospitals & medical practices, government organizations & research centers, pharmaceutical, biotechnology, and medical device companies, and others.


The cancer registry software market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.  


The European cancer registry software market has been segmented into Western Europe and Eastern Europe. Western Europe market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.   


The cancer registry software market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The market in the Middle East & Africa has been segmented into the Middle East and Africa.


News:


The GO2 Foundation for Lung Cancer announced the enhanced and extended Global Lung Cancer Registry to significantly advance lung cancer research by revealing hidden links between persons with lung cancer worldwide. The Global Lung Cancer Registry, an expansion of the GO2 Foundation's national registry, will securely collect information from lung cancer patients worldwide, giving researchers rich data to discover trends that could result in novel and better treatments for those with lung cancer. The registration will be accessible in Simplified Chinese, English, Spanish, German, and French the following year. Scientific investigation into how each person's disease interacts with or resists treatment has led to the development novel lung cancer medicines. To understand more about gene alterations and improve the quality of life for those undergoing therapy, researchers can examine interactions among cases within the Global Lung Cancer Registry. They can then use this information to develop medications and potential cures.


Regional Market Summary Cancer registry software market Share (%), by Region, 2018 Source: White Papers, Company Presentations, Annual Reports


On a regional basis, the Americas is anticipated to dominate the cancer registry software market owing to the rising prevalence of cancer, innovative product development and increasing investment in research and development for innovation in the region.   According to the National Cancer Institute, there were 1,735,350 new cases of cancer in the US in 2018.


Europe is expected to hold the second largest position in the market owing to the presence of strong academic & research base and availability of funding for research in the European countries.


Asia-Pacific is anticipated to be the fastest growing region in the market owing to the shift of pharmaceutical companies to countries such as India and China, which are low-cost manufacturing regions.


The Middle East & Africa has the least share of the cancer registry software market.  Moreover, the major market share of the region is expected to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.


Cancer Registry Software Market Segmentation


Cancer Registry Software Type Outlook



  • Integrated Software

  • Standalone Software


Cancer Registry Software Deployment Model Outlook



  • Cloud-Based Models

  • On-Premise Models


Cancer Registry Software Database Type Outlook



  • Commercial Databases

  • Public Databases


Cancer Registry Software Functionality Outlook



  • Patient Care Management

  • Product Outcome Evaluation

  • Cancer Reporting to Meet State and Federal Regulations

  • Medical Research & Clinical Studies


Cancer Registry Software End User Outlook



  • Hospitals & Medical Practices

  • Government Organizations & Research Centers

  • Pharmaceutical, Biotechnology, and Medical Device Companies

  • Others


Cancer Registry Software Region Outlook



  • Americas


    • North America


      • US

      • Canada


    • Latin America


  • Europe


    • Western Europe


      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe


    • Eastern Europe


  • Asia-Pacific


    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific


  • The Middle East & Africa


    • Middle East

    • Africa




Cancer registry software market, by Key Players



  • Onco, Inc.

  • Rocky Mountain Cancer Data Systems

  • McKesson Corporation

  • Elekta AB (PUB)

  • C/Net Solutions

  • Electronic Registry Systems, Inc.

  • ROCKY MOUNTAIN CANCER DATA SYSTEMS

  • MCKESSON CORPORATION

  • ORDINAL DATA, INC

  • CONDUENT, INC

  • IBM

  • HIMAGINE SOLUTIONS INC



Recent Development


In May 2022


Veeva Systems has declared that Lucid Diagnostics Inc., a commercial-stage, which is a cancer prevention medical diagnostics company with an owned subsidiary of PAVmed Inc., has selected Veeva Vault CDMS for capturing electronic data, coding, and data cleaning in the upcoming research EsoGuard in patients who are undergoing standard for, and management of, esophageal adenocarcinoma.


In May 2022


Taipei Veteran’s General Hospital is a first-class medical center and teaching hospital in Taiwan. TVGH and a major electronics brand joined forces in AI-based medicine for intensive care of early warning systems for shock and an individualized cancer treatment system.


Together, the hospital-private sector collaboration declared their result in the field of AI-based precision medicine. They established a warning system for shock in intensive care patients. In addition, the collaboration has led to the analysis of patients with hepatobiliary cancer, rectal, and gastrointestinal. It is used to predict a patient’s disease duration and treatment outcomes. 


Intended Audience



  • Software companies

  • Contract research organizations

  • Academic and research institutes

  • Government associations

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.